59 related articles for article (PubMed ID: 3630312)
1. [Change in the diameter of the coronary vessels following sublingual or intravenous nifedipine administration correlated with the plasma level].
Nellessen U; Rafflenbeul W; Jost S; Daniel W; Hecker H; Lichtlen PR
Z Kardiol; 1987 Jun; 76(6):329-39. PubMed ID: 3630312
[TBL] [Abstract][Full Text] [Related]
2. Effects of nifedipine and nitrates on coronary vasomotion.
Nellessen U; Rafflenbeul W; Jost S; Daniel WG; Hecker H; Lichtlen PR
Eur Heart J; 1988 Jan; 9 Suppl A():83-8. PubMed ID: 3409918
[TBL] [Abstract][Full Text] [Related]
3. Correlation between isosorbide dinitrate plasma levels and coronary vasodilation after chewing capsules.
Jost S; Rafflenbeul W; Knop I; Bossaller C; Reil GH; Gulba D; Hecker H; Lichtlen P
Z Kardiol; 1989; 78 Suppl 2():106-8; discussion 115-7. PubMed ID: 2588759
[TBL] [Abstract][Full Text] [Related]
4. Coronary vasodilation with dihydropyridines--a pharmacokinetic study.
Jost S; Rafflenbeul W; Mogwitz B; Nellessen U; Bossaller C; Zwicky P; Hecker H; Lippolt P; Lichtlen PR
Eur Heart J; 1989 Nov; 10 Suppl F():147-52. PubMed ID: 2620681
[TBL] [Abstract][Full Text] [Related]
5. Coronary vasodilation with nitrocompounds--is there a maximum?
Jost S; Reil G; Knop I; Rafflenbeul W; Auricchio A; Frombach R; Gulba D; Hecker H; Lichtlen P
Z Kardiol; 1989; 78 Suppl 2():38-40; discussion 64-7. PubMed ID: 2511691
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of prophylactic nifedipine therapy during aortocoronary vein bypass interventions. Drug concentration with oral or intravenous nifedipine administration; hemodynamics and plasma catecholamines].
Barankay A; Späth P; Remien J; Richter JA
Herz; 1990 Aug; 15(4):266-75. PubMed ID: 2210598
[TBL] [Abstract][Full Text] [Related]
7. [Acute coronary vasomotor effects of nifedipine and its therapeutic efficacy in syndrome X].
Montorsi P; Cozzi S; Loaldi A; Fabbiocchi F; Annoni L; De Cesare N; Polese A; Guazzi MD
Cardiologia; 1990 Oct; 35(10):851-6. PubMed ID: 2093432
[TBL] [Abstract][Full Text] [Related]
8. The effect of sublingual nifedipine on coronary venous graft resistance immediately following cardiopulmonary bypass.
Eide TR; Katz RI; Poppers PJ
Anesth Analg; 1989 Apr; 68(4):462-6. PubMed ID: 2929979
[TBL] [Abstract][Full Text] [Related]
9. [The effect of intravenous nifedipine administration on coronary occlusion during coronary angioplasty on ischemia tolerance and collateral function].
Ischinger T; Coppenrath K; Antoni D; Nowak F; Delius W
Z Kardiol; 1990 Mar; 79(3):166-75. PubMed ID: 2191507
[TBL] [Abstract][Full Text] [Related]
10. Assessment of sublingual isosorbide dinitrate and intracoronary nifedipine during ergonovine provocation.
Bethge HD; Bachmann K
Z Kardiol; 1983; 72 Suppl 3():92-7. PubMed ID: 6666236
[TBL] [Abstract][Full Text] [Related]
11. Bioavailability and pharmacokinetics of nifedipine administered by different routes in healthy volunteers.
Palma-Aguirre JA; Rosas-Alcázar G; Rodríguez JM; León-Urrea F; Montoya-Cabrera MA
Arch Invest Med (Mex); 1989; 20(2):129-35. PubMed ID: 2604495
[TBL] [Abstract][Full Text] [Related]
12. Effects of nifedipine on esophageal motor function in humans: correlation with plasma nifedipine concentration.
Hongo M; Traube M; McAllister RG; McCallum RW
Gastroenterology; 1984 Jan; 86(1):8-12. PubMed ID: 6689676
[TBL] [Abstract][Full Text] [Related]
13. [Ischemia tolerance of the heart in percutaneous transluminal coronary angioplasty. Controlled study of the effect of isosorbide dinitrate and nifedipine].
Erbel R; Hüttemann M; Schreiner G; Darius N; Pop T; Meyer J
Herz; 1987 Aug; 12(4):302-11. PubMed ID: 2958398
[TBL] [Abstract][Full Text] [Related]
14. Nifedipine serum concentrations following sublingual and oral doses.
Brown GR; Fraser DG; Castile JA; Gaudreault P; Platt DR; Friedman PA
Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):283-6. PubMed ID: 3733277
[TBL] [Abstract][Full Text] [Related]
15. [Effect of intracoronary and intravenous administration of propranolol on coronary vasomotility at rest and during exercise].
Bortone A; Hess OM; Gaglione A; Locuratolo N; Troito G; Rizzon P; Chiddo A
Cardiologia; 1989 Aug; 34(8):679-88. PubMed ID: 2605578
[TBL] [Abstract][Full Text] [Related]
16. Effects of nifedipine on coronary vasculature in canine models of dynamic and fixed coronary stenoses.
Yokoyama M; Sakamoto S; Kusui A; Akita H; Maekawa K; Fukuzaki H
J Pharmacol Exp Ther; 1985 Jun; 233(3):845-52. PubMed ID: 4009492
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of sublingual verapamil in patients with severe essential hypertension: comparison with sublingual nifedipine.
Al-Waili NS; Hasan NA
Eur J Med Res; 1999 May; 4(5):193-8. PubMed ID: 10336409
[TBL] [Abstract][Full Text] [Related]
18. [Anti-angina effectiveness of the calcium antagonist nifedipine in relation to coronary involvement].
Schulz W; Jost S; Kaltenbach M; Kober G
Z Kardiol; 1983 Nov; 72(11):657-64. PubMed ID: 6362245
[TBL] [Abstract][Full Text] [Related]
19. Comparison of effects of nifedipine and nitroglycerin on large and small coronary arteries and cardiac function in conscious dogs.
Hintze TH; Vatner SF
Circ Res; 1983 Feb; 52(2 Pt 2):I139-46. PubMed ID: 6403258
[TBL] [Abstract][Full Text] [Related]
20. [Effect of nifedipine and nitroglycerin on epicardial vessels in coronary heart disease].
Schanzenbächer P; Göttfert G; Kahles H; Liebau G; Maisch B; Riegger G; Kochsiek K
Dtsch Med Wochenschr; 1984 Apr; 109(17):656-60. PubMed ID: 6425031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
